The influence of the sinonasal microbiome on the development and management of rhinosinusitis
DOI:
https://doi.org/10.12775/JEHS.2025.77.56769Keywords
microbiome, nasal polyps, rhinosinusitisAbstract
Introduction and purpose: Chronic rhinosinusitis (CRS) is a frequently diagnosed condition in patients seeking medical care. It encompasses a range of disorders that can be classified based on underlying causes, clinical symptoms, or inflammatory types. Although the precise cause of CRS remains unclear, the European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020) has recently offered updated insights, treatment strategies, and recommendations.
State of knowledge: Recent research has increasingly focused on the role of the microbiota in inflammatory diseases. The optimal bacterial environment in the sinonasal mucosa, where inhaled bacteria, viruses, fungal spores, and particles initially interact, is still not fully understood. The dysbiosis theory, which emphasizes the importance of the microbiome and its relationship with the host, is the predominant model explaining CRS pathogenesis. Disruptions in this balance can lead to a variety of clinical manifestations in CRS patients.
Conclusions: Given the impact of CRS treatment on the composition of sinus and nasopharyngeal microbiota, the dysbiosis theory highlights the importance of addressing this aspect in therapeutic strategies. Ongoing research is exploring the potential use of pre- and probiotics as novel treatment options. A more thorough understanding of the microbiological factors involved in CRS is crucial for developing personalized, targeted therapies for affected individuals.
References
Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg 2015;152:S1–39. https://doi.org/10.1177/0194599815572097.
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020;58:1–464. https://doi.org/10.4193/Rhin20.600.
Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of chronic rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract 2022;10:1395–403. https://doi.org/10.1016/j.jaip.2022.01.016.
Zawadzka-Głos L. Microbiota and antibiotic therapy in rhinosinusitis. Otolaryngol Pol 2023;77:36–42. https://doi.org/10.5604/01.3001.0053.8709.
Stevens WW, Peters AT, Tan BK, Klingler AI, Poposki JA, Hulse KE, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract 2019;7:2812-2820.e3. https://doi.org/10.1016/j.jaip.2019.05.009.
Kato A. Immunopathology of chronic rhinosinusitis. Allergol Int 2015;64:121–30. https://doi.org/10.1016/j.alit.2014.12.006.
Herbert DR, Douglas B, Zullo K. Group 2 innate lymphoid cells (ILC2): type 2 immunity and helminth immunity. Int J Mol Sci 2019;20. https://doi.org/10.3390/ijms20092276.
Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M. Adult-onset eosinophilic airway diseases. Allergy 2020;75:3087–99. https://doi.org/10.1111/all.14620.
Delemarre T, Bachert C. Neutrophilic inflammation in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2023;23:14–21. https://doi.org/10.1097/ACI.0000000000000868.
De Corso E, Baroni S, Onori ME, Tricarico L, Settimi S, Moretti G, et al. Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP. Acta Otorhinolaryngol Ital 2022;42:355–63. https://doi.org/10.14639/0392-100X-N1800.
Xu X, Reitsma S, Wang DY, Fokkens WJ. Highlights in the advances of chronic rhinosinusitis. Allergy 2021;76:3349–58. https://doi.org/10.1111/all.14892.
Hamilos DL. Drivers of chronic rhinosinusitis: Inflammation versus infection. J Allergy Clin Immunol 2015;136:1454–9. https://doi.org/10.1016/j.jaci.2015.10.011.
Fokkens WJ, Reitsma S. Medical algorithms: Management of chronic rhinosinusitis. Allergy 2019;74:1415–6. https://doi.org/10.1111/all.13797.
Ahern S, Cervin A. Inflammation and Endotyping in Chronic Rhinosinusitis-A Paradigm Shift. Medicina (Kaunas) 2019;55. https://doi.org/10.3390/medicina55040095.
Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract 2020;8:1505–11. https://doi.org/10.1016/j.jaip.2019.12.021.
Tomassen P, Vandeplas G, Van Zele T, Cardell L-O, Arebro J, Olze H, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 2016;137:1449-1456.e4. https://doi.org/10.1016/j.jaci.2015.12.1324.
Corriveau M-N, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009;23:461–5. https://doi.org/10.2500/ajra.2009.23.3367.
Psaltis AJ, Mackenzie BW, Cope EK, Ramakrishnan VR. Unraveling the role of the microbiome in chronic rhinosinusitis. J Allergy Clin Immunol 2022;149:1513–21. https://doi.org/10.1016/j.jaci.2022.02.022.
Huntley KS, Raber J, Fine L, Bernstein JA. Influence of the microbiome on chronic rhinosinusitis with and without polyps: an evolving discussion. FrontAllergy 2021;2:737086. https://doi.org/10.3389/falgy.2021.737086.
Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho D-Y, Holmes S, et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe 2013;14:631–40. https://doi.org/10.1016/j.chom.2013.11.005.
Cho D-Y, Hunter RC, Ramakrishnan VR. The microbiome and chronic rhinosinusitis. Immunol Allergy Clin North Am 2020;40:251–63. https://doi.org/10.1016/j.iac.2019.12.009.
Robinson CM, Pfeiffer JK. Viruses and the microbiota. Annu Rev Virol 2014;1:55–69. https://doi.org/10.1146/annurev-virology-031413-085550.
Liao B, Hu C-Y, Liu T, Liu Z. Respiratory viral infection in the chronic persistent phase of chronic rhinosinusitis. Laryngoscope 2014;124:832–7. https://doi.org/10.1002/lary.24348.
Ramadan HH, Farr RW, Wetmore SJ. Adenovirus and respiratory syncytial virus in chronic sinusitis using polymerase chain reaction. Laryngoscope 1997;107:923–5. https://doi.org/10.1097/00005537-199707000-00017.
Zhao YC, Bassiouni A, Tanjararak K, Vreugde S, Wormald P-J, Psaltis AJ. Role of fungi in chronic rhinosinusitis through ITS sequencing. Laryngoscope 2018;128:16–22. https://doi.org/10.1002/lary.26702.
Sivasubramaniam R, Douglas R. The microbiome and chronic rhinosinusitis. World J Otorhinolaryngol Head Neck Surg 2018;4:216–21. https://doi.org/10.1016/j.wjorl.2018.08.004.
Marsland BJ, Trompette A, Gollwitzer ES. The Gut-Lung Axis in Respiratory Disease. Ann Am Thorac Soc 2015;12 Suppl 2:S150-6. https://doi.org/10.1513/AnnalsATS.201503-133AW.
Copeland E, Leonard K, Carney R, Kong J, Forer M, Naidoo Y, et al. Chronic rhinosinusitis: potential role of microbial dysbiosis and recommendations for sampling sites. Front Cell Infect Microbiol 2018;8:57. https://doi.org/10.3389/fcimb.2018.00057.
Cleland EJ, Bassiouni A, Vreugde S, Wormald P-J. The bacterial microbiome in chronic rhinosinusitis: Richness, diversity, postoperative changes, and patient outcomes. Am J Rhinol Allergy 2016;30:37–43. https://doi.org/10.2500/ajra.2016.30.4261.
Aurora R, Chatterjee D, Hentzleman J, Prasad G, Sindwani R, Sanford T. Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg 2013;139:1328–38. https://doi.org/10.1001/jamaoto.2013.5465.
Abreu NA, Nagalingam NA, Song Y, Roediger FC, Pletcher SD, Goldberg AN, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med 2012;4:151ra124. https://doi.org/10.1126/scitranslmed.3003783.
Chalermwatanachai T, Vilchez-Vargas R, Holtappels G, Lacoere T, Jáuregui R, Kerckhof F-M, et al. Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota. Sci Rep 2018;8:7926. https://doi.org/10.1038/s41598-018-26327-2.
Wei H-Z, Li Y-C, Wang X-D, Lu X-X, Hu C-H, He S, et al. The microbiology of chronic rhinosinusitis with and without nasal polyps. Eur Arch Otorhinolaryngol 2018;275:1439–47. https://doi.org/10.1007/s00405-018-4931-6.
Niederfuhr A, Kirsche H, Riechelmann H, Wellinghausen N. The bacteriology of chronic rhinosinusitis with and without nasal polyps. Arch Otolaryngol Head Neck Surg 2009;135:131–6. https://doi.org/10.1001/archoto.2008.531.
Liu CM, Soldanova K, Nordstrom L, Dwan MG, Moss OL, Contente-Cuomo TL, et al. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol 2013;3:775–81. https://doi.org/10.1002/alr.21195.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012;23:3 p preceding table of contents, 1–298.
Jervis-Bardy J, Wormald P-J. Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery. Int Forum Allergy Rhinol 2012;2:111–5. https://doi.org/10.1002/alr.20106.
Liu CM, Kohanski MA, Mendiola M, Soldanova K, Dwan MG, Lester R, et al. Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota. Int Forum Allergy Rhinol 2015;5:185–90. https://doi.org/10.1002/alr.21467.
Banuelos J, Lu NZ. A gradient of glucocorticoid sensitivity among helper T cell cytokines. Cytokine Growth Factor Rev 2016;31:27–35. https://doi.org/10.1016/j.cytogfr.2016.05.002.
Strehl C, Ehlers L, Gaber T, Buttgereit F. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System. Front Immunol 2019;10:1744. https://doi.org/10.3389/fimmu.2019.01744.
Jain R, Hoggard M, Biswas K, Zoing M, Jiang Y, Douglas R. Changes in the bacterial microbiome of patients with chronic rhinosinusitis after endoscopic sinus surgery. Int Forum Allergy Rhinol 2017;7:7–15. https://doi.org/10.1002/alr.21849.
Habermann W, Zimmermann K, Skarabis H, Kunze R, Rusch V. [Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin]. Arzneimittelforschung 2002;52:622–7. https://doi.org/10.1055/s-0031-1299941.
Mukerji SS, Pynnonen MA, Kim HM, Singer A, Tabor M, Terrell JE. Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial. Otolaryngol Head Neck Surg 2009;140:202–8. https://doi.org/10.1016/j.otohns.2008.11.020.
Michalik M, Podbielska-Kubera A, Basińska AM, Szewc M, Gałęcka M, Schwiertz A. Alteration of indicator gut microbiota in patients with chronic sinusitis. Immun Inflamm Dis 2023;11:e996. https://doi.org/10.1002/iid3.996.
Lee JT, Frank DN, Ramakrishnan V. Microbiome of the paranasal sinuses: Update and literature review. Am J Rhinol Allergy 2016;30:3–16. https://doi.org/10.2500/ajra.2016.30.4255.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Miriam Lang, Dawid Bereza, Maria Kulak-Waśniewska, Igor Moreau, Paulina Polańska, Katarzyna Sokołowska, Barbara Woch
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 381
Number of citations: 0
